COVID-19 medicines under evaluation

The European Medicines Agency (EMA) is evaluating potential COVID-19 vaccines and treatments to enable promising medicines to reach patients in the European Union (EU) as soon as possible.

COVID-19 vaccines under marketing authorisation evaluation

There are currently no COVID-19 medicines under evaluation by EMA's Committee for Medicinal Products for Human Use (CHMP).